- Reported purity
- 99.28%99.0–99.49%
- Test date
- Sep 6, 2026
- Laboratory named
- Freedom Diagnostics
Lot details
PH-11-10-0710
Loading peptide prices…
Loading peptide prices…
Compare observed vial prices, price per mg, and current indexed COA records across vendors.
Indexed documents do not establish product quality. Missing means we have not indexed one. Index as of Oct 2026.
Price-drop alert
Today’s lowest in-stock price is $3.80/mg. We check daily and email you once if it drops 10% or more. The alert ends after that, or after six months.
Some outbound vendor links are affiliate links. Commission status does not change the displayed prices, indexed COA fields, or certificate filters.
Observed market data
Document coverage, not product quality.
Observed Thymosin Alpha-1 listings span $22.54-$200 in total vial price, with a median of $8 per mg across 146 usable listings as of Oct 5, 2026. Compare observed Thymosin Alpha-1 vial listings by total price, price per mg, vial size, stock status, and last-checked date. This market view does not recommend a seller or verify a product for clinical use. Observed vial prices do not include clinician visits, pharmacy compounding, injection supplies, shipping, or other treatment-related costs. Each vendor row shows its current COA record, including the reported purity, named lab, and printed test date.
Observed Thymosin Alpha-1 listings span $22.54-$200 in total vial price, with a median of $8 per mg across 146 usable listings as of Oct 5, 2026.
The comparison covers observed vial prices and price per mg. Observed vial prices do not include clinician visits, pharmacy compounding, injection supplies, shipping, or other treatment-related costs.
The index has a current certificate on file for 48 of 134 tracked Thymosin Alpha-1 vendors, with 168 public documents. Vendors may have testing that we have not indexed.
Choose “Highest COA purity” to sort vendors by the value printed on each current certificate. The number belongs to that document, lab, lot, and test date. It cannot establish product quality or safety, and values from different labs or methods are not directly comparable.
Product documentation
Current certificates are on file for 48 of 134 tracked vendors. The public evidence set contains 168 documents naming 13 laboratories. Reported test dates in this set run from Jan 7, 2024 through Sep 6, 2026.
86 tracked vendors have no current certificate in this index. Those vendors may have testing we have not indexed.
48 current records
PH-11-10-0710
TA1-05
BTCS-ZY-56-517
TA1-010-MH-03
Clear Pink Cap
2608-218
1750
THA0001
TA0404
Red Cap
THY10001
ULP-36004A
GB0006YF
TUY-060326
TA1006222026
AMP-TA11006052026-04
EZP-TA11006052026-04
982444TU
B002
PP2602-041A
TA05260910H
3548699
33-05260828
TAXV042603
C73756
Black Cap
2026-03-30
TA10-03232026
BX-JH906
2026-02-27 (Vial 1)
TA202082
WLLTA-1-10-10001
0012600
8201947365
25-3013
FP25-0082
TY10/2025-04
TA-00001A
2024010701
20200519027
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
Lab, lot, date, compound, and purity fields are transcribed from the document and can contain extraction errors. “Older record” means the reported test date is more than 18 months old.
Learn how to read a peptide COA or review the testing methodology and dataset.
The clinic network
Request a free connection to a peptide clinic, by telehealth or in person. A licensed clinician decides whether any treatment is right for you. What peptide therapy involves